150 related articles for article (PubMed ID: 33228683)
1. Identifying and understanding determinants of high healthcare costs for breast cancer: a quantile regression machine learning approach.
Hu L; Li L; Ji J; Sanderson M
BMC Health Serv Res; 2020 Nov; 20(1):1066. PubMed ID: 33228683
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Total End-of-Life Health Care Costs of Medicare Beneficiaries: A Quantile Regression Forests Analysis.
Li L; Hu L; Ji J; Mckendrick K; Moreno J; Kelley AS; Mazumdar M; Aldridge M
J Gerontol A Biol Sci Med Sci; 2022 May; 77(5):1065-1071. PubMed ID: 34153101
[TBL] [Abstract][Full Text] [Related]
3. Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data.
Mazumdar M; Lin JJ; Zhang W; Li L; Liu M; Dharmarajan K; Sanderson M; Isola L; Hu L
BMC Health Serv Res; 2020 Apr; 20(1):350. PubMed ID: 32334595
[TBL] [Abstract][Full Text] [Related]
4. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
5. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
6. Modeling Episode-Based Payments for Cancer Using Commercial Claims Data.
Polson M; Lord T; Evangelatos T; Kangethe A; Speicher LC; Barrientos S; Zacker C
J Manag Care Spec Pharm; 2019 Feb; 25(2):235-245. PubMed ID: 30698092
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
8. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
[TBL] [Abstract][Full Text] [Related]
9. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
10. Association of the Oncology Care Model With Value-Based Changes in Use of Radiation Therapy.
Kapadia NS; Brooks GA; Landrum MB; Riedel L; Liu PH; Hassol A; Tripp AS; Jhatakia S; Kummet CM; Keating NL
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):39-46. PubMed ID: 35150787
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
[TBL] [Abstract][Full Text] [Related]
12. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
[TBL] [Abstract][Full Text] [Related]
13. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
Sagar B; Lin YS; Castel LD
J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.
Daniel GW; Malone DC
J Manag Care Pharm; 2007 Mar; 13(2):142-54. PubMed ID: 17330975
[TBL] [Abstract][Full Text] [Related]
15. Machine learning approaches for predicting high cost high need patient expenditures in health care.
Yang C; Delcher C; Shenkman E; Ranka S
Biomed Eng Online; 2018 Nov; 17(Suppl 1):131. PubMed ID: 30458798
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care Model.
Dreyer TRF; Hamilton E; Dahl A; Desai B; Kircher S; Polite B; Schroeder C; Fukui M; Hayes-Lattin B; Horvath KA
JCO Oncol Pract; 2022 Nov; 18(11):e1899-e1907. PubMed ID: 36252153
[TBL] [Abstract][Full Text] [Related]
17. A Machine Learning Approach to Support Urgent Stroke Triage Using Administrative Data and Social Determinants of Health at Hospital Presentation: Retrospective Study.
Chen M; Tan X; Padman R
J Med Internet Res; 2023 Jan; 25():e36477. PubMed ID: 36716097
[TBL] [Abstract][Full Text] [Related]
18. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
Wu VS; Khlopin M; Jagsi R; McClelland S
Pract Radiat Oncol; 2024; 14(1):24-27. PubMed ID: 37748680
[TBL] [Abstract][Full Text] [Related]
19. Multiple Myeloma Cost of Care Under the Oncology Care Model: The Influence of High-Cost Therapies.
Theroux H; Williams A; Liu M; Dahl A; Dreyer T; Horvath K; Isola L
JCO Oncol Pract; 2020 Oct; 16(10):e1078-e1084. PubMed ID: 32459566
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US.
Slabaugh SL; Curtis BH; Clore G; Fu H; Schuster DP
J Med Econ; 2015 Feb; 18(2):106-12. PubMed ID: 25333214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
